These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 27694579

  • 1. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
    Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON.
    Proc Natl Acad Sci U S A; 2016 Oct 18; 113(42):E6457-E6466. PubMed ID: 27694579
    [Abstract] [Full Text] [Related]

  • 2. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J, Ci X, Xue H, Wu R, Dong X, Choi SYC, He H, Wang Y, Zhang F, Qu S, Zhang F, Haegert AM, Gout PW, Zoubeidi A, Collins C, Gleave ME, Lin D, Wang Y.
    Eur Urol; 2018 Jun 18; 73(6):949-960. PubMed ID: 29544736
    [Abstract] [Full Text] [Related]

  • 3. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C, Wu G, Li R, Gao L, Yang F, Zhao Y, Zhang J, Zhang R, Zhang J, Yao L, Yuan J, Li X.
    Cancer Biol Ther; 2015 Jun 18; 16(2):287-96. PubMed ID: 25756511
    [Abstract] [Full Text] [Related]

  • 4. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
    Ruscetti M, Dadashian EL, Guo W, Quach B, Mulholland DJ, Park JW, Tran LM, Kobayashi N, Bianchi-Frias D, Xing Y, Nelson PS, Wu H.
    Oncogene; 2016 Jul 21; 35(29):3781-95. PubMed ID: 26640144
    [Abstract] [Full Text] [Related]

  • 5. Tpl2 induces castration resistant prostate cancer progression and metastasis.
    Lee HW, Cho HJ, Lee SJ, Song HJ, Cho HJ, Park MC, Seol HJ, Lee JI, Kim S, Lee HM, Choi HY, Nam DH, Joo KM.
    Int J Cancer; 2015 May 01; 136(9):2065-77. PubMed ID: 25274482
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ, Binge LC, Sriratana A, Wang H, Robinson PA, Pook D, Fedele CG, Brown S, Dyson JM, Cottle DL, Cowling BS, Niranjan B, Risbridger GP, Mitchell CA.
    Cancer Res; 2013 Aug 15; 73(16):5066-79. PubMed ID: 23801747
    [Abstract] [Full Text] [Related]

  • 7. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
    Thamilselvan V, Menon M, Thamilselvan S.
    Int J Cancer; 2016 Oct 01; 139(7):1632-47. PubMed ID: 27198552
    [Abstract] [Full Text] [Related]

  • 8. ERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells.
    Tome-Garcia J, Li D, Ghazaryan S, Shu L, Wu L.
    PLoS One; 2014 Oct 01; 9(6):e99525. PubMed ID: 24937171
    [Abstract] [Full Text] [Related]

  • 9. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
    Barboro P, Benelli R, Tosetti F, Costa D, Capaia M, Astigiano S, Venè R, Poggi A, Ferrari N.
    Carcinogenesis; 2020 Sep 24; 41(9):1246-1252. PubMed ID: 32525968
    [Abstract] [Full Text] [Related]

  • 10. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
    Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG.
    Clin Cancer Res; 2016 Sep 01; 22(17):4505-16. PubMed ID: 27060154
    [Abstract] [Full Text] [Related]

  • 11. Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.
    Liu YN, Niu S, Chen WY, Zhang Q, Tao Y, Chen WH, Jiang KC, Chen X, Shi H, Liu A, Li J, Li Y, Lee YC, Zhang X, Huang J.
    Clin Cancer Res; 2019 Jul 01; 25(13):4128-4140. PubMed ID: 30962287
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M, Liu X, Guo J, Weng X, Jiang G, Wang Z, He L.
    Biochem Biophys Res Commun; 2015 Nov 13; 467(2):310-5. PubMed ID: 26435505
    [Abstract] [Full Text] [Related]

  • 13. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G, Wang J, Feng C, Jiang H, Xu J, Ding Q.
    Oncotarget; 2016 Sep 27; 7(39):64309-64317. PubMed ID: 27602760
    [Abstract] [Full Text] [Related]

  • 14. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y.
    Int J Biochem Cell Biol; 2013 Dec 27; 45(12):2736-48. PubMed ID: 24076216
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
    Shen Y, Cao J, Liang Z, Lin Q, Wang J, Yang X, Zhang R, Zong J, Du X, Peng Y, Zhang J, Shi J.
    Cell Commun Signal; 2019 May 23; 17(1):50. PubMed ID: 31122254
    [Abstract] [Full Text] [Related]

  • 16. PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor.
    Wang Y, Wu X, Ou L, Yang X, Wang X, Tang M, Chen E, Luo C.
    Cancer Lett; 2015 Jun 28; 362(1):61-9. PubMed ID: 25796442
    [Abstract] [Full Text] [Related]

  • 17. ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer.
    Fararjeh AS, Liu YN.
    Int J Mol Sci; 2019 Jun 08; 20(11):. PubMed ID: 31181727
    [Abstract] [Full Text] [Related]

  • 18. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH, Park SJ, Dickinson SI, Luo JL.
    Mol Cell; 2017 Jan 05; 65(1):154-167. PubMed ID: 28041912
    [Abstract] [Full Text] [Related]

  • 19. Integrated network model provides new insights into castration-resistant prostate cancer.
    Hu Y, Gu Y, Wang H, Huang Y, Zou YM.
    Sci Rep; 2015 Nov 25; 5():17280. PubMed ID: 26603105
    [Abstract] [Full Text] [Related]

  • 20. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
    Liu ZJ, Xiao M, Balint K, Smalley KS, Brafford P, Qiu R, Pinnix CC, Li X, Herlyn M.
    Cancer Res; 2006 Apr 15; 66(8):4182-90. PubMed ID: 16618740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.